Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bayer Gets FDA Approval for New Topical Treatment - Beauty Packaging

What are you searching for?

Sign in
Beauty Industry

Bayer Gets FDA Approval for New Topical Treatment

The FDA has approved Bayer HealthCare’s new topical treatment for rosacea.

Author Image

By: Marie Redding

Senior Editor, Rodman Media

Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has approved Finacea (azelaic acid) Foam, 15% for the topical treatment of mild to moderate rosacea. The product has an affect on the rosacea’s inflammatory papules and pustules.

The approval is based on results from two clinical trials.

“The FDA approval of Finacea® Foam is the result of several years of research and development,” said James Robins, VP & General Manager, Bayer HealthCare Pharmaceuticals Inc. “Not only does it add to our current product line, it also demonstrates Bayer’s continued commitment to addressing the needs of patients with mild to moderate rosacea.”
Finacea Foam will be available by prescription only beginning in September 2015.

Add us as a preferred source on Google

Get the latest Beauty Packaging news, insights and analysis in your Google Search and AI experiences.

Add Beauty Packaging as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Beauty Packaging Newsletters

Topics